Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Citigroup Maintains Buy on Amdocs, Raises Price Target to $99

Citigroup Maintains Buy on Amdocs, Raises Price Target to $99

Citigroup analyst Ashwin Shirvaikar maintains Amdocs (NASDAQ:DOX) with a Buy and raises the price target from $90 to $99.

August 4, 2022

1 minute read

Citigroup analyst Ashwin Shirvaikar maintains Amdocs (NASDAQ:DOX) with a Buy and raises the price target from $90 to $99.

Amazon Receives FDA Warning Letter For OTC Mole Removal Products

August 9, 2:38 PM

The FDA’s Center for Drug Evaluation and Research released a warning letter sent to Amazon Inc’s (NASDAQ:AMZN) CEO Andy Jassy for selling…

January 6, 7:58 AM

JP Morgan analyst Jimmy Bhullar maintains Aflac (NYSE:AFL) with a Neutral and raises the price target from $62 to $66.

July 27, 10:22 AM

Baird analyst Andrew Wittmann maintains Ecolab (NYSE:ECL) with a Outperform and lowers the price target from $193 to $171.

April 12, 12:00 PM

Throughout the last three months, 4 analysts have evaluated Oaktree Specialty Lending (NASDAQ:OCSL), offering a diverse set of…